Your institution may have access to this item. Find your institution then sign in to continue.
Title
Decitabine.
Authors
Gore, Steven D.; Jones, Carole; Kirkpatrick, Peter
Abstract
Decitabine (Dacogen; MGI Pharma), a nucleoside analogue that inhibits DNA methylation, was approved by the US FDA for the treatment of myelodysplastic syndromes in May 2006.
Publication
Nature Reviews Drug Discovery, 2006, Vol 5, Issue 11, p891